1-4 of 4
Hamed A Daw, MD
Close
Sort by
Journal Articles

Evaluation of Conventional Cytogenetics Versus Fluorescence in Situ Hybridization Analysis in the Prognostic Scoring of Patients with Myelodysplastic Syndromes.

Baidehi Maiti, MD, PhD, Raymond Chahoud, Timothy P Spiro, MD, Hamed A Daw, MD
Journal: Blood
Blood (2009) 114 (22): 1757.
https://doi.org/10.1182/blood.V114.22.1757.1757
Published: 2009
Journal Articles

Modified International Prognostic Score (IPS) for Predicting the Need for Bone Marrow Biopsy (BMB) in Hodgkin's Lymphoma (HL).

Alaa A Muslimani, M.D., Timothy Spiro, Asif A. Chaudhry, MD, Harris C Taylor, Ishmael Jaiyesimi, Praveen Vashist, MBBS, MD, Hamed A Daw, MD
Journal: Blood
Blood (2009) 114 (22): 3661.
https://doi.org/10.1182/blood.V114.22.3661.3661
Published: 2009
Journal Articles

Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients?.

Alaa A. Muslimani, MD, Timothy P. Spiro, MD, FACP, Asif A. Chaudhry, MD, Hamed A. Daw, MD
Journal: Blood
Blood (2007) 110 (11): 1878.
https://doi.org/10.1182/blood.V110.11.1878.1878
Published: 2007
Journal Articles

Successful Use of Recombinant Factor VIIa in Reversal of Life Threatening Bleeding Caused by Coagulopathy.

Alaa A. Muslimani, MD, Harneet K. Walia, MD, Manmeet S. Ahluwalia, MD, H. L. Daneschvar, MD, Hamed A. Daw, MD
Journal: Blood
Blood (2005) 106 (11): 4077.
https://doi.org/10.1182/blood.V106.11.4077.4077
Published: 2005